Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 34

1.

Longitudinal Adherence to Immunochemical Fecal Occult Blood Testing vs Guaiac-based FOBT in an Organized Colorectal Cancer Screening Program.

Benito L, Travier N, Binefa G, Vidal C, Espinosa J, Milà N, Garcia M.

Cancer Prev Res (Phila). 2019 May;12(5):327-334. doi: 10.1158/1940-6207.CAPR-18-0091. Epub 2019 Mar 19.

PMID:
30890542
2.

Testing behavioral interventions to optimize participation in a population-based colorectal cancer screening program in Catalonia, Spain.

Stoffel S, Benito L, Milà N, Travier N, Binefa G, Vidal C, Espinosa J, Moreno V, Garcia M.

Prev Med. 2019 Feb;119:58-62. doi: 10.1016/j.ypmed.2018.12.013. Epub 2018 Dec 28.

PMID:
30594532
3.

Factors related to longitudinal adherence in colorectal cancer screening: qualitative research findings.

Benito L, Farre A, Binefa G, Vidal C, Cardona A, Pla M, García M.

Cancer Causes Control. 2018 Jan;29(1):103-114. doi: 10.1007/s10552-017-0982-z. Epub 2017 Nov 23.

4.

Population-based Cancer Screening: Measurement of Coordination and Continuity of Care.

Benito L, Espinosa J, Binefa G, Vidal C, Lluch MT, Puig M, Fernandez M, Padrol I, García M.

Cancer Nurs. 2018 Jul/Aug;41(4):E1-E11. doi: 10.1097/NCC.0000000000000514.

PMID:
28622194
5.

Corrigendum: Risk Model for Colorectal Cancer in Spanish Population Using Environmental and Genetic Factors: Results from the MCC-Spain study.

Ibáñez-Sanz G, Díez-Villanueva A, Alonso MH, Rodríguez-Moranta F, Pérez-Gómez B, Bustamante M, Martin V, Llorca J, Amiano P, Ardanaz E, Tardón A, Jiménez-Moleón JJ, Peiró R, Alguacil J, Navarro C, Guinó E, Binefa G, Fernández-Navarro P, Espinosa A, Dávila-Batista V, Molina AJ, Palazuelos C, Castaño-Vinyals G, Aragonés N, Kogevinas M, Pollán M, Moreno V.

Sci Rep. 2017 May 17;7:46807. doi: 10.1038/srep46807. No abstract available.

6.

Risk Model for Colorectal Cancer in Spanish Population Using Environmental and Genetic Factors: Results from the MCC-Spain study.

Ibáñez-Sanz G, Díez-Villanueva A, Alonso MH, Rodríguez-Moranta F, Pérez-Gómez B, Bustamante M, Martin V, Llorca J, Amiano P, Ardanaz E, Tardón A, Jiménez-Moleón JJ, Peiró R, Alguacil J, Navarro C, Guinó E, Binefa G, Fernández-Navarro P, Espinosa A, Dávila-Batista V, Molina AJ, Palazuelos C, Castaño-Vinyals G, Aragonés N, Kogevinas M, Pollán M, Moreno V.

Sci Rep. 2017 Feb 24;7:43263. doi: 10.1038/srep43263. Erratum in: Sci Rep. 2017 May 17;7:46807. Navarro, Pablo Fernández [corrected to Fernández-Navarro, Pablo].

7.

Cross-sectional survey on awareness of colorectal cancer and a screening programme for primary health care professionals in Catalonia, Spain.

Benito L, García M, Binefa G, Mila N, Vidal C, Lluch MT, Puig M; Primary Care-Screening Working Group.

Eur J Cancer Care (Engl). 2016 Nov;25(6):992-1004. doi: 10.1111/ecc.12450. Epub 2016 Feb 16.

PMID:
26880138
8.

Incidence of advanced neoplasia during surveillance in high- and intermediate-risk groups of the European colorectal cancer screening guidelines.

Cubiella J, Carballo F, Portillo I, Cruzado Quevedo J, Salas D, Binefa G, Milà N, Hernández C, Andreu M, Terán Á, Arana-Arri E, Ono A, Valverde MJ, Bujanda L, Hernández V, Morillas JD, Jover R, Castells A.

Endoscopy. 2016 Nov;48(11):995-1002. Epub 2016 Aug 2.

PMID:
27485482
9.

False-negative rate cannot be reduced by lowering the haemoglobin concentration cut-off in colorectal cancer screening using faecal immunochemical test.

Ibañez-Sanz G, Garcia M, Milà N, Rodríguez-Moranta F, Binefa G, Gómez-Matas J, Benito L, Padrol I, Barenys M, Moreno V.

Eur J Cancer Prev. 2017 Sep;26(5):365-367. doi: 10.1097/CEJ.0000000000000281.

PMID:
27433880
10.

Prescription drugs associated with false-positive results when using faecal immunochemical tests for colorectal cancer screening.

Ibáñez-Sanz G, Garcia M, Rodríguez-Moranta F, Binefa G, Gómez-Matas J, Domènech X, Vidal C, Soriano A, Moreno V; ‘Adverse Effects on Colorectal Cancer Screening in Catalonia (EACC) Study’ Working Group.

Dig Liver Dis. 2016 Oct;48(10):1249-54. doi: 10.1016/j.dld.2016.06.011. Epub 2016 Jun 21.

PMID:
27378703
11.

[How to assess and reduce social inequalities in cancer screening programmes].

Binefa G, García M, Peiró R, Molina-Barceló A, Ibáñez R; en nombre de los participantes del encuentro «¿Cómo reducir las desigualdades sociales en los programas de cribado de cáncer?».

Gac Sanit. 2016 May-Jun;30(3):232-4. doi: 10.1016/j.gaceta.2016.01.008. Epub 2016 Feb 23. Spanish.

12.

Colorectal Cancer Screening Programme in Spain: Results of Key Performance Indicators After Five Rounds (2000-2012).

Binefa G, Garcia M, Milà N, Fernández E, Rodríguez-Moranta F, Gonzalo N, Benito L, Clopés A, Guardiola J, Moreno V.

Sci Rep. 2016 Jan 20;6:19532. doi: 10.1038/srep19532.

13.

[Interval cancers and episode sensitivity in population-based screening programmes for colorectal cancer: a systematic review].

Domènech X, Garcia M, Benito L, Binefa G, Vidal C, Milà N, Moreno V.

Gac Sanit. 2015 Nov-Dec;29(6):464-71. doi: 10.1016/j.gaceta.2015.07.002. Epub 2015 Sep 2. Review. Spanish.

14.

An urgent referral strategy for symptomatic patients with suspected colorectal cancer based on a quantitative immunochemical faecal occult blood test.

Rodríguez-Alonso L, Rodríguez-Moranta F, Ruiz-Cerulla A, Lobatón T, Arajol C, Binefa G, Moreno V, Guardiola J.

Dig Liver Dis. 2015 Sep;47(9):797-804. doi: 10.1016/j.dld.2015.05.004. Epub 2015 May 15.

PMID:
26055489
15.

Interval cancers in a population-based screening program for colorectal cancer in catalonia, Spain.

Garcia M, Domènech X, Vidal C, Torné E, Milà N, Binefa G, Benito L, Moreno V.

Gastroenterol Res Pract. 2015;2015:672410. doi: 10.1155/2015/672410. Epub 2015 Feb 24.

16.

Postpolypectomy surveillance in patients with adenomas and serrated lesions: a proposal for risk stratification in the context of organized colorectal cancer-screening programs.

Castells A, Andreu M, Binefa G, Fité A, Font R, Espinàs JA.

Endoscopy. 2015 Jan;47(1):86-7. doi: 10.1055/s-0034-1378100. Epub 2014 Dec 22. No abstract available.

PMID:
25532113
17.

Fecal hemoglobin concentration as a measure of risk to tailor colorectal cancer screening: are we there yet?

Garcia M, Milà N, Binefa G, Benito L, Gonzalo N, Moreno V.

Eur J Cancer Prev. 2015 Jul;24(4):321-7. doi: 10.1097/CEJ.0000000000000090.

PMID:
25370684
18.

Defining the role of the nurse in population-based cancer screening programs.

Benito L, Binefa G, Lluch T, Vidal C, Milà N, Puig M, Roldán J, Garcia M.

Clin J Oncol Nurs. 2014 Aug;18(4):E77-83. doi: 10.1188/14.CJON.E77-E83. Review.

PMID:
25095308
19.

Use of text-message reminders to improve participation in a population-based breast cancer screening program.

Vidal C, Garcia M, Benito L, Milà N, Binefa G, Moreno V.

J Med Syst. 2014 Sep;38(9):118. doi: 10.1007/s10916-014-0118-x. Epub 2014 Jul 30.

PMID:
25073694
20.

Colorectal cancer: from prevention to personalized medicine.

Binefa G, Rodríguez-Moranta F, Teule A, Medina-Hayas M.

World J Gastroenterol. 2014 Jun 14;20(22):6786-808. doi: 10.3748/wjg.v20.i22.6786. Review.

21.

Colonoscopy quality assessment in a mass population screening programme based on faecal occult blood test.

Binefa G, García M, Milà N, Rodríguez L, Rodríguez-Moranta F, Guardiola J, Moreno V.

Rev Esp Enferm Dig. 2013 Aug;105(7):400-8.

22.

False-positive results from colorectal cancer screening in Catalonia (Spain), 2000-2010.

Garcia M, Milà N, Binefa G, Borràs JM, Espinàs JA, Moreno V.

J Med Screen. 2012 Jun;19(2):77-82. doi: 10.1258/jms.2012.012013. Epub 2012 May 31.

PMID:
22653571
23.

[Colorectal cancer screening: actions have been taken and the cart has been put behind the horse].

Guayta-Escolies R, Castells A, Macià F, Binefa G; Grupo de Investigación del Programa de Prevención del Cáncer de Colon y Recto (PROCOLON).

Gac Sanit. 2012 May-Jun;26(3):289; author reply 289-90. doi: 10.1016/j.gaceta.2011.11.009. Epub 2012 Mar 7. Spanish. No abstract available.

24.

[Adherence to a population-based colorectal cancer screening program in Catalonia (Spain), 2000-2008].

Milà N, García M, Binefa G, Borràs JM, Espinàs JA, Moreno V.

Gac Sanit. 2012 May-Jun;26(3):217-22. doi: 10.1016/j.gaceta.2011.10.020. Epub 2012 Feb 22. Spanish.

25.

Repeated screening for colorectal cancer with fecal occult blood test in Catalonia, Spain.

Garcia M, Borràs JM, Binefa G, Milà N, Espinàs JA, Moreno V.

Eur J Cancer Prev. 2012 Jan;21(1):42-5. doi: 10.1097/CEJ.0b013e32834a7e9b.

PMID:
21849903
26.

Factors associated with initial participation in a population-based screening for colorectal cancer in Catalonia, Spain: a mixed-methods study.

García M, Borràs JM, Milà N, Espinàs JA, Binefa G, Fernández E, Farré A, Pla M, Cardona A, Moreno V.

Prev Med. 2011 Mar-Apr;52(3-4):265-7. doi: 10.1016/j.ypmed.2011.01.012. Epub 2011 Feb 2.

PMID:
21295061
27.

Colorectal cancer screening: strategies to select populations with moderate risk for disease.

Navarro M, Binefa G, Blanco I, Guardiola J, Rodríguez-Moranta F, Peris M; Catalan Colorectal Cancer Screening Pilot Programme Group.

Rev Esp Enferm Dig. 2009 Dec;101(12):855-60.

28.

[Colorectal cancer in a population with a guaiac-based screening programme].

Navarro M, Peris M, Binefa G, Vanaclocha M, Losa F, Fernández E.

Med Clin (Barc). 2009 Apr 11;132(13):495-500. doi: 10.1016/j.medcli.2008.12.026. Epub 2009 Apr 7. Spanish.

PMID:
19356774
29.

Colorectal cancer mortality in Spain: trends and projections for 1985-2019.

Ribes J, Navarro M, Clèries R, Esteban L, Pareja L, Binefa G, Peris M, Fernández E, Borràs JM.

Eur J Gastroenterol Hepatol. 2009 Jan;21(1):92-100. doi: 10.1097/MEG.0b013e32830b5f39.

PMID:
19011574
30.

[Colonoscopic findings from a pilot screening study for colorectal cancer in Catalonia].

Navarro M, Peris M, Binefa G, Nogueira JM, Miquel JM, Espinás JA, Borrás JM; Catalan Colorectal Cancer Screening Pilot Programme Group.

Rev Esp Enferm Dig. 2008 Jun;100(6):343-8. Spanish.

31.

Lessons learnt from a population-based pilot programme for colorectal cancer screening in Catalonia (Spain).

Peris M, Espinàs JA, Muñoz L, Navarro M, Binefa G, Borràs JM; Catalan Colorectal Cancer Screening Pilot Programme Group.

J Med Screen. 2007;14(2):81-6.

PMID:
17626707
32.

[Survival changes among AIDS cases in Catalonia, Spain (1981-2001)].

Rius C, Binefa G, Montoliu A, Esteve A, Ribas G, Gispert R, Casabona J.

Med Clin (Barc). 2006 Jul 1;127(5):167-71. Spanish.

PMID:
16834951
33.

[Reporting of newly diagnosed HIV infections in Catalonia, Barcelona, Spain. Implementation and results].

Romaguera A, Binefa G, Casabona J, García de Olalla P, Caylà J, Camps N, Company M, Minguell S, Godoy P, Sala MR, Humet V, Alvarez J, Barrabeig I; Grupo de médicos coordinadores de VIH/sida.

Gac Sanit. 2005 Sep-Oct;19(5):356-62. Spanish.

34.

[Epidemiology of HIV/AIDS infection and relationship with other sexually transmitted diseases (STD). Future prospects].

Rius C, Binefa G, Casabona J.

Enferm Infecc Microbiol Clin. 2004 Aug-Sep;22(7):419-29. Spanish.

PMID:
15355772

Supplemental Content

Loading ...
Support Center